Bioleaders Corporation (142760) — Cash Flow Reinvestment Rate
Bioleaders Corporation (142760) has a Cash Flow Reinvestment Rate of 76.60x as of September 2024, reinvesting ₩3.80 Billion (capex ₩1.04 Billion plus investments ₩2.75 Billion) from operating cash flow of ₩49.56 Million. See 142760 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bioleaders Corporation Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for Bioleaders Corporation across 1 annual periods. For the full cash flow conversion analysis, see 142760 operating cash flow.
Annual Cash Flow Reinvestment Rate for Bioleaders Corporation (2023–2023)
Year-by-year capital reinvestment analysis for Bioleaders Corporation. See financial flexibility index of Bioleaders Corporation to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 5.01x | ₩30.93 Billion | ₩6.18 Billion | ₩378.81 Million | — |